Cross-Shareholdings

Basic Policy

The Company holds shares as cross-shareholdings when it determines that they will contribute to enhancing corporate value over the medium to long term through their strategic importance to the Group’s business and the maintenance and strengthening of business relationships.
At the same time, the Company recognizes improving capital efficiency as an important management priority in implementing management that is conscious of the cost of capital and share price. Accordingly, the Board of Directors reviews and verifies its cross-shareholdings annually, taking into consideration the purpose of each holding, the status of business relationships, profitability and growth potential, as well as the benefits of holding the shares in comparison with the cost of capital.
Based on the results of these reviews, the Company reduces its holdings of shares that are deemed to have insufficient strategic significance, taking into account dialogue with the companies whose shares are held.
In exercising voting rights, the Company makes a comprehensive judgment from the perspective of contributing to the enhancement of the corporate value and shareholder value of the companies whose shares are held.
Going forward, the Company will continue to improve asset efficiency through the reduction of cross-shareholdings, thereby contributing to further improvements in ROE and PBR.

Reduction in Cross-Shareholdings

Reduction in Cross-Shareholdings

List of Cross-Shareholdings

Specified equity securities

Securities Number of shares Holding of the Company’s shares
FY2025 FY2024
Mitsubishi UFJ Financial Group, Inc. 1,193,854 1,193,854 Yes
OSAKA SODA CO., LTD. 1,230,000 1,230,000 Yes
Inabata & Co., Ltd. 393,300 393,300 Yes
Zeria Pharmaceutical Co., Ltd. 374,000 374,000 Yes
Mebuki Financial Group, Inc. 620,100 620,100 Yes
Iyogin Holdings, Inc. 194,875 194,875 Yes
TODA CORPORATION 282,200 282,200 Yes
The Toho Bank, Ltd. 600,000 600,000 Yes
Takeda Pharmaceutical Company Limited 50,000 50,000 Yes
DAIKIN INDUSTRIES, LTD. 8,800 8,800 Yes
YUKI GOSEI KOGYO CO., LTD. 366,000 366,000 Yes
VITAL KSK HOLDINGS, INC. 93,460 93,460 Yes
Sankyu Inc. 14,674 14,674 Yes
SUZUKEN CO., LTD. 21,232 21,232 Yes
HOKUYAKU TAKEYAMA Holdings, Inc. 112,500 112,500 Yes
Daito Pharmaceutical Co., Ltd. 48,400 24,200 Yes
C’ BON COSMETICS Co., Ltd. 17,300 17,300 Yes
Mitsubishi HC Capital Inc. - 500,000 No
CAC Holdings Corporation - 200,900 No
KAGA ELECTRONICS CO., LTD. - 142,000 Yes
MEDIPAL HOLDINGS CORPORATION - 136,911 No

Deemed holdings of equity securities

Securities Number of shares Holding of the Company’s shares
FY2025 FY2024
Sumitomo Mitsui Financial Group, Inc. 138,600 138,600 Yes